|
1
|
Nakashima T, Yasumatsu R, Asai K, Uryu H,
Kogo R and Nakagawa T: Single-cycle induction chemotherapy for
resectable advanced hypopharyngeal cancer. Int J Clin Oncol.
22:442–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonner J, Giralt J, Harari P, Spencer S,
Schulten J, Hossain A, Chang SC, Chin S and Baselga J: Cetuximab
and radiotherapy in laryngeal preservation for cancers of the
larynx and hypopharynx: A secondary analysis of a randomized
clinical trial. JAMA Otolaryngol Head Neck Surg. 142:842–849. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Damascelli B, Patelli G, Ticha V, Di Tolla
G, Frigerio LF, Garbagnati F, Lanocita R, Marchianò A, Spreafico C,
Mattavelli F, et al: Feasibility and efficacy of percutaneous
transcatheter intraarterial chemotherapy with paclitaxel in albumin
nanoparticles for advanced squamous-cell carcinoma of the oral
cavity, oropharynx, and hypopharynx. J Vasc Interv Radiol.
18:1395–1403. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoo GH, Moon J, Leblanc M, Lonardo F, Urba
S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J and Wolf G: A
phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53)
gene therapy followed by chemoradiotherapy for advanced, resectable
squamous cell carcinoma of the oral cavity, oropharynx,
hypopharynx, and larynx: Report of the Southwest Oncology Group.
Arch Otolaryngol Head Neck Surg. 135:869–874. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hess AK, Müer A, Mairinger FD, Weichert W,
Stenzinger A, Hummel M, Budach V and Tinhofer I: MiR-200b and
miR-155 as predictive biomarkers for the efficacy of chemoradiation
in locally advanced head and neck squamous cell carcinoma. Eur J
Cancer. 77:3–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang L, Mou Y, Meng D, Sun Y, Chen X, Yang
X, Jia C, Song X and Li X: MicroRNA-203 inhibits tumour growth and
metastasis through PDPN. Clin Otolaryngol. 42:620–628. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Si F, Sun J and Wang C: MicroRNA-138
suppresses cell proliferation in laryngeal squamous cell carcinoma
via inhibiting EZH2 and PI3K/AKT signaling. Exp Ther Med.
14:1967–1974. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang B, Qin H, Wang Y, Chen W, Luo J, Zhu
X, Wen W and Lei W: Effect of DJ-1 overexpression on the
proliferation, apoptosis, invasion and migration of laryngeal
squamous cell carcinoma SNU-46 cells through PI3K/AKT/mTOR. Oncol
Rep. 32:1108–1116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Wang Y and Wang J: MicroRNA-584
inhibits cell proliferation and invasion in non-small cell lung
cancer by directly targeting MTDH. Exp Ther Med. 15:2203–2211.
2018.PubMed/NCBI
|
|
11
|
Liu J, Lei DP, Jin T, Zhao XN, Li G and
Pan XL: Altered expression of miR-21 and PTEN in human laryngeal
and hypopharyngeal squamous cell carcinomas. Asian Pac J Cancer
Prev. 12:2653–2657. 2011.PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Elliott EA, Wright JR, Swann RS,
Nguyen-Tân F, Takita C, Bucci MK, Garden AS, Kim H, Hug EB, Ryu J,
et al: Phase III Trial of an emulsion containing trolamine for the
prevention of radiation dermatitis in patients with advanced
squamous cell carcinoma of the head and neck: Results of radiation
therapy oncology group trial 99-13. J Clin Oncol. 24:2092–2097.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Durmus K, Kucur C, Uysal IO, Dziegielewski
PT and Ozer E: Feasibility and clinical outcomes of transoral
robotic surgery and transoral robot-assisted carbon dioxide laser
for hypopharyngeal carcinoma. J Craniofac Surg. 26:235–237. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Orosz E, Gombos K, Riedling T, Afiakurue
P, Kiss I, Pytel J, Gerlinger I and Szanyi I: Comparative miRNA
expression profile analysis of squamous cell carcinoma and
peritumoral mucosa from the meso- and hypopharynx. Cancer Genomics
Proteomics. 14:285–292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Re M, Magliulo G, Gioacchini FM,
Bajraktari A, Bertini A, Çeka A, Rubini C, Ferrante L, Procopio AD
and Olivieri F: Expression levels and clinical significance of
miR-21-5p, miR-let-7a, and miR-34c-5p in laryngeal squamous cell
carcinoma. Biomed Res Int. 2017:39212582017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Tang Y, Cui H, Zhao X, Luo X, Pan
W, Huang X and Shen N: Let-7/miR-98 regulate Fas and Fas-mediated
apoptosis. Genes Immun. 12:149–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Li C, Li H, Zhang T, Hao X, Chang J
and Xu Y: MicroRNA-30a-5p suppresses tumor cell proliferation of
human renal cancer via the MTDH/PTEN/AKT pathway. Int J Mol Med.
41:1021–1029. 2018.PubMed/NCBI
|
|
19
|
Mizrak Kaya D, Dong X, Nogueras-González
GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter
WL, Maru DM, et al: Post-trimodality expression levels of
metadherin (MTDH) as a prognostic biomarker for esophageal
adenocarcinoma patients. Med Oncol. 34:1352017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiao W, Cao N and Yang L: MicroRNA-154
inhibits the growth and metastasis of gastric cancer cells by
directly targeting MTDH. Oncol Lett. 14:3268–3274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang GL, Wu YB, Liu JT and Li CY:
Upregulation of miR-98 inhibits apoptosis in cartilage cells in
osteoarthritis. Genet Test Mol Biomarkers. 20:645–653. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo XM, Xu B, Zhou ML, Bao YY, Zhou SH,
Fan J and Lu ZJ: Co-Inhibition of GLUT-1 expression and the
PI3K/Akt signaling pathway to enhance the radiosensitivity of
laryngeal carcinoma xenografts in vivo. PLoS One. 10:e01433062015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang XJ and Jia SS: Fisetin inhibits
laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2
signaling pathways. Biomed Pharmacother. 83:1164–1174. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Z, Wang M, He Q, Li Z, Zhao Y, Wang
W, Ma J, Li Y and Chang G: MicroRNA-98 rescues proliferation and
alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1.
Exp Ther Med. 13:1702–1710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu XL, Wang ZF, Lei WB, Zhuang HW, Hou
WJ, Wen YH and Wen WP: Tumorigenesis role and clinical significance
of DJ-1, a negative regulator of PTEN, in supraglottic squamous
cell carcinoma. J Exp Clin Cancer Res. 31:942012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Guo D and Li C: Downregulation of
miRNA-26b inhibits cancer proliferation of laryngeal carcinoma
through autophagy by targeting ULK2 and inactivation of the
PTEN/AKT pathway. Oncol Rep. 38:1679–1687. 2017. View Article : Google Scholar : PubMed/NCBI
|
